In response to neurotransmitters, astrocytes show various types of calcium increase (transient, oscillatory, and complex), the physiological significance of which is still controversial. To explore this variability, we examined factors affecting the calcium increase pattern in cultured astrocytes and investigated the consequences of the astrocytic calcium response in slice preparations. We found that growth factors (GFs) (EGF plus basic FGF) promoted calcium oscillation in response to glutamate, ATP, or thimerosal (which directly activates the inositol-1,4,5 triphosphate receptor) and that this effect was suppressed by pro-inflammatory cytokines (interleukin-1␤ or tumor necrosis factor-␣), lipopolysaccharide, or a MEK (mitogen-activated protein kinase kinase) inhibitor, suggesting dual regulation of calcium oscillation in astrocytes by factors affecting brain function and pathology via the mitogen-activated protein kinase (MAPK) cascade. The calcium oscillation was accompanied by enlargement of the calcium store, cell proliferation, and the development of a hypertrophic morphology. The cytokines suppressed GF-induced MAPK-dependent immediate early gene promoter activation, but not phosphorylation of extracellular signal-regulated kinase (ERK), showing that they affected gene regulation by acting on the MAPK cascade downstream of ERK. In slice preparations, a metabotropic glutamate receptor agonist converted the spontaneous neuronal calcium increase, attributable to synaptic transmission, to an oscillatory response similar to that seen in astrocytes in culture, indicating that the calcium response in astrocytes acted as a feedback mechanism on the activity of neighboring neurons. This is the first evidence for a dual regulation of calcium oscillation by physiological factors and for the control of calcium dynamics actually being used in physiological processes.
Introduction
Calcium imaging and the identification of receptor genes have provided useful information about the astrocytic calcium response to neurotransmitters (Verkhratsky et al., 1998) and have suggested a dynamic role for astrocytes in brain function (Haydon, 2001 ). Astrocytes, which form the largest population of nonexcitable cells in the mammalian CNS, adhere closely to neurons and blood vessels and fill the space between them (Zonta et al., 2003) . This anatomical property is advantageous not only in the regulation of CNS metabolism but also for the interaction of astrocytes with neurotransmitters released from nerve terminals. During neuronal activity, astrocytes respond by an increase in intracellular calcium levels (Pasti et al., 1997) , but many aspects of this response have not been well studied, for instance, the degree of neuronal activity required and the consequences for brain function.
In this study, we cultured astrocytes in serum-free defined medium and examined the effects of growth factors (GFs) and cytokines on calcium dynamics. Although astrocytes have been studied by calcium imaging for Ͼ10 years, their reported pharmacological properties and response pattern vary (transient or oscillatory), depending on the species, brain region, and age of the animal (McCarthy and Salm, 1991; Muller et al., 1997; Cai et al., 2000) , and this complexity makes it difficult to determine the physiological role of these phenomena. We propose that this variability could reflect an important function of astrocytes, namely that they can respond to factors, such as ions, neurotransmitters, bioactive lipid metabolites, GFs, cytokines, and adhesion molecules, in the CNS environment and can alter the environment by changing their morphology and metabolism, including the expression of enzymes and other factors (Rostworowski et al., 1997; Stachowiak et al., 1997; Krushel et al., 1998; Verkhratsky et al., 1998; Xian and Zhou, 1999; Bezzi et al., 2001) . These responses are important in maintaining CNS homeostasis but would cause significant variation in the results of studies on cultured astrocytes. Small differences in culture conditions, such as cell density, serum, and the presence of other cell populations, affect astrocyte metabolism by the presence of soluble factors or by cell adhesion, leading to further changes in the medium. Because of this synergistic effect, initial small differences can produce markedly different results. To avoid these issues and to examine the real properties of astrocytes, it is necessary to culture them in well defined conditions, for which serum-free defined medium is ideal. The use of defined medium allows the effect of the environment on the physiological properties of astrocytes to be systematically studied and should provide important new information on astrocyte function. Calcium oscillation is reported to generate repetitive glutamate release from astrocytes that then affects surrounding neurons (Pasti et al., 1997 (Pasti et al., , 2001 , suggesting a feedback mechanism from the astrocyte to the neuronal network. We therefore studied calcium oscillation in astrocytes cultured in defined medium and compared these responses with those in tissue slice preparations to determine whether our culture system results could be applied to in vivo studies.
Materials and Methods
Cell culture and calcium imaging. Astrocytes were isolated from the cerebral cortex of postnatal day 1 Wistar rats, using a modification of the method described by Levison and McCarthy (1991) . Briefly, brain cells were prepared from the cortices of 10 -15 brains by trypsinization, trituration, and filtration, and seeded at 1.3 ϫ 10 4 cells/cm 2 in 75 cm 2 plastic flasks (Sumitomo Bakelite, Tokyo, Japan). After culture for 12 d at 37°C in 5% CO 2 humidified air in basal Eagle's medium containing 10% fetal calf serum (FCS) (Equitech-Bio, Ingram, TX) with a medium change every 3 d, the resulting mixed glia culture was shaken at 260 rpm for 18 hr at 37°C and then rinsed with medium to remove nonastrocytic cells. The adherent cells were subcultured by trypsinization and seeded at a density of 3 ϫ 10 4 cells/cm 2 in DMEM (Asahi Technoglass, Funabashi, Japan) containing 25 mM HEPES, pH 7.4, and 10% FCS on either poly-D-lysine-coated coverslips (for calcium imaging or immunocytochemistry) or plastic plates (Asahi Technoglass) (for Western blotting or reporter gene assays). After 48 hr, the medium was changed to that described in each experiment, and culture continued for an additional 48 -96 hr before assay. The astrocyte-defined medium (ADM), a modified version of that reported by Miller et al. (1995) , consisted of DMEM containing 25 mM HEPES, pH 7.4, 1 mM pyruvate, 2 mM glutamine, 50 mg/ml human apotransferrin (Invitrogen, Gaithersburg, MD), 10 ng/ml D-biotin, 5.2 ng/ml sodium selenite, 1.5 mg/ml bovine fibronectin (Invitrogen), 0.5 mg/ml heparin sulfate, 5 mg/ml insulin (Invitrogen), 10 ng/ml epidermal growth factor (EGF) (Invitrogen), and 5 ng/ml basic fibroblast growth factor (bFGF) (Invitrogen); GF-free ADM had the same composition, but lacked the EGF and bFGF. Rat interleukin-1␤ (IL-1␤) and rat tumor necrosis factor-␣ (TNF␣) were obtained from Peprotech (London, UK). For calcium imaging, the cells were washed three times and then loaded for 45 min at 37°C with 7.5 M fura-2 AM (Dojin, Kumamoto, Japan) in basal salt saline (BSS) consisting of (in mM): 129 NaCl, 4 KCl, 1 MgCl 2 , 2 CaCl 2 , 4.2 glucose, and 10 HEPES, the pH being adjusted to 7.4 with NaOH. In all steps after loading, 100 M sulfinpyrazone was added to the BSS. After washing and incubation at room temperature for 20 min, the coverslips were mounted in a chamber (RC-26; Warner Instruments, Hamden, CT) and perfused at a rate of 1.5 ml/min. Calcium imaging was performed using an IX70 inverted microscope, a UApo/340 40ϫ/1.15w objective, and an OSP-EXA filter exchanger (all from Olympus, Tokyo, Japan) equipped with a C6790 CCD camera (Hamamatsu Photonics, Hamamatsu, Japan). Fluorescence images were acquired and ratio images (R340/380) calculated using AQUA-COSMOS software (Hamamatsu Photonics). For quantitative analysis of calcium oscillation, the nuclei were visualized by staining using acridine orange and UV illumination, a newly developed method (Morita et al., 2003) . In each imaging experiment, 20 -40 cells were identified; each histogram shows the results from six imaging experiments from two series of cultures prepared from two different preparations of cells.
Immunological detection. Immunocytochemical staining for glial fibrillary acidic protein (GFAP) was performed using a rabbit polyclonal anti-GFAP antibody (5 g/ml; Dako, Hamburg, Germany) and rhodamine-conjugated goat second antibody (5 g/ml; Chemicon, Temecula, CA). For counterstaining of the nucleus, Hoechst 33258 (1 M) was added to the second antibody solution. To assess metabotropic glutamate receptor-5 (mGluR5) expression, Western blotting was performed using rabbit polyclonal anti-mGluR5 antibody (2 g/ml; Upstate Biotechnology, Lake Placid, NY) or mouse monoclonal anti-actin antibody (1:1000 dilution; Chemicon). To assess extracellular signalregulated kinase (ERK) phosphorylation, cells on six-well plates were cultured in GF-free ADM for 48 hr and pretreated either overnight with cytokines or lipopolysaccharide (LPS) or for 5 min with the mitogenactivated protein (MAP) kinase kinase (MEK) inhibitor; then GFs were added for 5 min, and Western blotting was performed using mouse monoclonal antibody against phosphorylated ERK (2 g/ml; Sigma, St. Louis, MO) or rabbit polyclonal anti-ERK antibody (0.6 g/ml; Sigma). Horseradish peroxidase-conjugated secondary antibody from Amersham Biosciences (Buckinghamshire, UK) was used to detect all bound primary antibodies.
Reporter gene assay. The promoter region of the rat early growth response gene-1 (egr-1) gene (Ϫ525 to ϩ117) (Changelian et al., 1989) was obtained by PCR and subcloned into pGL3-Basic (Promega, Madison, WI). This reporter gene vector was transfected, using TransFast (Promega), into astrocytes that had been grown for 48 hr in DMEM containing 25 mM HEPES, pH 7.4, and 1% FCS. After 24 hr, the medium was changed to GF-free ADM, and then, after 48 hr culture, with or without pretreatment, as described for the Western blot experiments above, GFs were added for 6 hr, and luciferase activity was assayed using PicaGene (Nippon Gene, Tokyo, Japan).
Slice culture and calcium imaging. Slice cultures were prepared from the hippocampus of postnatal day 7 Wistar rats, as described previously (Hirasawa et al., 2000) , and cultured for 7-14 d before calcium imaging. BSS containing 0.1 mM ascorbic acid and 0.5 mM inositol was used throughout, and sulfinpyrazone was included as described for the cell culture experiments. The cells were incubated with 50 M MK801 for 30 min before and during loading for 1 hr at 37°C with fluo-4 AM (Molecular Probes, Eugene, OR) in BSS containing 0.005% Cremophore. After three washes, the slices were incubated for 30 min at room temperature in medium without MK801 and then were transferred for 5 min to BSS containing 100 mM mannitol, which suppresses swelling during pharmacological stimulation. Calcium imaging was performed using an E600FN upright microscope and a Fluor 40ϫ/0.8w objective (both from Nikon, Tokyo, Japan) equipped with a CSU-10 laser confocal scanning unit (Yokokawa, Tokyo, Japan), a 532R-BS-A04 argon laser (Melles Griot, Irvine, CA), and a C6790 CCD camera (Hamamatsu). Fluorescence images were acquired using AQUACOSMOS software (Hamamatsu), and the fluorescence ratio (F/Fo) was calculated from the average intensity of the indicated areas.
Results
Growth factor-induced calcium oscillation As in a previous report (Jensen and Chiu, 1990) , astrocytes cultured in medium containing 10% FCS, a commonly used additive, were found to consist of a mixture of two populations, the proportions of which varied between cultures. One of these showed a transient response, and the other an oscillatory response, to glutamate (30 M) or ATP (100 M) ( Fig. 1 A, top panels); the percentage of responding cells showing oscillatory responses to glutamate or ATP, respectively, was 33.3% (n ϭ 42) and 18.9% (n ϭ 58). In contrast, after culture for 48 -96 hr in serum-free defined medium containing EGF and bFGF (ADM), almost all of the responding cells showed calcium oscillation (center panels). Typical imaging data for the calcium oscillation in response to glutamate are shown in the supplementary data (movie 1; available at www.jneurosci.org). Furthermore, these cells showed a similar oscillatory response to thimerosal (10 M), which affects the redox state of the inositol-1,4,5 triphosphate (IP 3 ) receptor and induces calcium release (Swann, 1991) . In contrast, cells in GF-free ADM gave a transient response to all three stimuli (bottom panels). The percentage of responding cells showing oscillatory responses to glutamate, ATP, or thimerosal, respectively, was 10.3% (n ϭ 156), 8.3% (n ϭ 60), and 3.6% (n ϭ 56) in GF-free ADM and 75.0% (n ϭ 212), 74% (n ϭ 85), and 80.0% (n ϭ 128) in ADM.
Although it has been reported previously that this same set of GFs increases astrocyte mGluR5 expression, enhances phosphoinositide hydrolysis and the calcium response, and converts the calcium response to oscillatory (Miller et al., 1995; Nakahara et al., 1997) , Western blotting showed no significant increase in mGluR5 protein levels in the presence of GFs over the same time course (Fig. 1 B) . These results show that the mixed calcium response seen in serum-containing medium could be converted to an entirely transient or entirely oscillatory response in serum-free medium depending on the absence or presence, respectively, of GFs, and that this conversion was mediated by changes in some calciumcontrolling mechanism. Because the effects of defined medium required Ͼ48 hr to become apparent (data not shown), we hypothesized that regulation of gene expression was involved and that the candidate genes would be those coding for proteins regulating intracellular calcium dynamics, such as calcium channels, pumps, exchangers, and buffer proteins.
Inhibition by cytokines or a MEK inhibitor GF production in the CNS changes during development, under different pathological conditions, and during functions such as memory formation and has been shown to affect astrocyte proliferation and their differentiation to reactive astrocytes (Stachowiak et al., 1997; Xian and Zhou, 1999) . Production of proinflammatory cytokines, such as IL1␤ and TNF␣, also changes with pathology and stress and is known to affect astrocyte proliferation, morphology, and metabolism (Rostworowski et al., 1997; Murray and Lynch, 1998; Herx and Yong, 2001 ). These two groups of factors (GFs and pro-inflammatory cytokines) competitively regulate the production of S100␤ or growth inhibitory factor by astrocytes (Hinkle et al., 1998; Uchida, 1999) and are produced with different time courses in brain injury, cytokine levels increasing within several hours after insult (Rostworowski et al., 1997) , whereas GF levels reach a maximum only after 1 week, when the scar of astrocytes becomes mature (Iseki et al., 2002) . On the basis of these results, we hypothesized that these soluble factors may have opposing effects and examined the effect of cytokines on the GF-induced calcium oscillation in astrocytes. We also examined the effects of LPS, which is known to activate a cellsignaling cascade similar to that activated by pro-inflammatory cytokines (Raetz and Whitfield, 2002) , and those of a MEK inhibitor, U0126, which attenuates the MAPK cascade, one of the main pathways activated by GFs (Favata et al., 1998) . Figure 2 A shows calcium responses of three representative cells cultured in ADM containing a pro-inflammatory cytokine (IL1␤ or TNF␣), LPS, or a MEK inhibitor, all of which suppressed the calcium oscillation induced by the GFs. To analyze these results quantitatively, individual cells were identified by nuclear staining with acridine orange after calcium imaging with fura-2 AM, and their calcium responses to 30 M glutamate were measured and plotted as frequency and amplitude histograms (Figs. 2 B, C) . The number of peaks seen during 2 min stimulation with glutamate was 4.12 Ϯ 0.20 (mean Ϯ SEM; n ϭ 228) and 1.04 Ϯ 0.05 (n ϭ 178) in ADM and GF-free ADM, respectively, indicating that the GFs caused a marked change in the pattern. Although the various agents tested gave different effects, giving frequencies between 0.90 and 2.04 peaks per 2 min in all cases, fewer peaks were seen than in ADM alone. The amplitude of the calcium response was also suppressed in parallel with the calcium oscillation. Because the percentage of cells showing no response increased from 7.0% in ADM and 9.8% in GF-free ADM to 24.9% in ADM plus LPS, 35.5% in ADM plus IL1␤, 56.7% in ADM plus TNF␣, and 47.4% in ADM plus U0126, the calcium responses were recalculated using only the responding cells, with similar results (shown in parentheses).
Enlargement of calcium stores
In astrocytes, glutamate presumably acts by inducing IP 3 -induced calcium release via mGluRs, because the calcium response was not induced by either kainic acid or NMDA, both of which act on ion channel-type glutamate receptors, but was induced by the group I mGluR agonist ( S)-3,5-dihydroxyphenylglycine or the more selective mGluR5 agonist (RS)-2-chloro-5- hydroxyphenylglycine (Conn and Pin, 1997 ) (data not shown). Because direct activation of the IP 3 receptor with thimerosal was sufficient to induce an oscillatory calcium response, the regulatory mechanisms of intracellular calcium dynamics were assumed to be the main target of factors affecting calcium oscillation, and we therefore investigated changes in the calcium store. To compare the sizes of the calcium store involved, the cells were treated with ionomycin in the absence of extracellular calcium, and the amount of released calcium was measured; this treatment abolished the glutamate-induced calcium release (Fig. 3A, left) , showing that it depleted the store required for calcium oscillation. In the absence of ionomycin treatment, astrocytes retained the ability to release calcium even after 6 min in the absence of extracellular calcium (Fig. 3A, right) . Figure 3B shows calcium release in astrocytes under different culture conditions. When we used this method to compare the size of the stores under each of these conditions, the calcium release in the presence of GFs was approximately twice that seen in their absence (Fig. 3C) and was decreased to an intermediate level by the presence of proinflammatory cytokines, LPS, or the MEK inhibitor, indicating that the enlargement of the calcium store by the GFs was suppressed in parallel with the calcium oscillation.
Morphology and calcium response
Under certain pathological conditions, astrocytes proliferate and become morphologically hypertrophic; this is known as differentiation into reactive astrocytes, a process in which GFs and proinflammatory cytokines are thought to be involved (Rostworowski et al., 1997; Iseki et al., 2002) . To investigate the relationship between differentiation and changes in the calcium response, we performed an immunocytochemical study using anti-GFAP antibody and Hoechst nuclear staining and examined astrocyte morphology and proliferation under different culture conditions. As shown in Figure 4 A, cells cultured in ADM bore more fibers staining strongly for GFAP, whereas those cultured in GF-free ADM were flat and showed mesh-like GFAP staining in the perinuclear region. IL1␤ or LPS partially suppressed the effect of GFs, i.e., the fibrous morphology and mesh-like structure were intermediate between those in ADM and those in GF-free ADM. The effect of the MEK inhibitor was more marked, the cells being flat, as in GF-free ADM, with mesh-like GFAP fibers surrounding the nuclei. Proliferation was quantified by calculating the cell density (Fig. 4 B) . The GFs promoted astrocyte proliferation; the density of cells cultured in GF-free ADM was only 65% of that of cells cultured in ADM. The densities of cells cultured in ADM containing IL␤, LPS, or the MEK inhibitor were 61, 73, or 73%, respectively, of that of cells grown in ADM, indicating suppression of the GF-induced proliferation by these compounds. These results show a correlation between proliferation and calcium oscillation of astrocytes. Expression of GFAP, which increases in the reactive astrocyte in situ (Brock and O'Callaghan, 1987) , was measured under the different culture conditions using Western blotting, but no significant differences were detected (data not shown). These results show that the GFs promoted proliferation and a hypertrophic morphology of astrocytes via the MAPK cascade and that these effects were blocked by pro-inflammatory cytokines and LPS. These changes correlated well with calcium oscillation, suggesting that calcium oscillation is a characteristic of a differentiation state of the astrocyte, possibly a reactive astrocyte. In addition, the results shown in Figure 4 B support the idea that astrocytes giving either transient or oscillatory responses are both derived from a single cell population. Although it is possible that the astrocytes with different responding patterns belong to different cell populations and that the GFs affect the proliferation of each population to a different extent, our results suggest this is not the case. The cell density, which was 3 ϫ 10 4 cells/cm 2 at seeding, increased to 4.8 Ϯ 0.2 ϫ 10 4 or 7.4 Ϯ 0.3 ϫ 10 4 cells/cm 2 in the absence or presence of GFs, respectively. Because the percentage of cells (responders and nonresponders) showing a nonoscillatory response decreased from ϳ90 to 30% in the presence of GFs (Fig. 2) , the GFs caused a decrease in the density of nonoscillatory cells from 4.3 ϫ 10 4 to 2.2 ϫ 10 4 cells/ cm 2 . Because GFs caused no significant cell death, and GFs would not be expected to suppress the proliferation, this reduction indicates that the GFs converted cells showing a nonoscillatory response to cells showing an oscillatory response.
MAPK and the immediate early gene
To examine the involvement of the MAPK cascade in these changes in the astrocyte, its activation was examined at two different levels, ERK phosphorylation and activation of the immediate early gene (IEG), in astrocytes cultured in the presence of factors affecting calcium dynamics. As shown in Figure 5A , in the presence of the GFs, ERK was phosphorylated within 5 min; this effect was slightly enhanced by the cytokines and LPS, which did not themselves activate ERK, although they have been reported to activate this cascade in astrocytes (Molina-Holgado et al., 2000) , but was abolished completely by pretreatment with the MEK inhibitor. Furthermore, we monitored gene activation via the MAPK cascade in a reporter gene assay using the IEG promoter. egr-1, which has six serum response elements and two cAMP response elements in the promoter region and encodes a transcription factor that is known to control bFGF production via the MAPK cascade in astrocytes, was used to construct the reporter gene vector (Changelian et al., 1989; Biesiada et al., 1996; Harada et al., 1996) . As shown in Figure 5B , the GFs caused gene activation within 6 hr, and this was suppressed by pretreatment with the pro-inflammatory cytokines, LPS, or the MEK inhibitor. As in the ERK phosphorylation experiment, the cytokines or LPS did not themselves activate the reporter gene (data not shown). These results show that the GFs activated the MAPK cascade and sub- sequent IEG expression and that the cytokines and LPS affected these processes downstream of ERK activation and suppressed gene regulation in the cascade.
Calcium oscillation in slice preparations
To elucidate the role of the astrocytic calcium response in brain function, we investigated changes in neuronal network activity after astrocyte stimulation. In hippocampal acute slice preparations, an mGluR agonist, (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid (tACPD), induces a calcium response in astrocytes and then in neighboring neurons, and because ionotropic GluR (iGluR) antagonists inhibit only the neuronal calcium increase, it was suggested that tACPD induces both a calcium increase in, and glutamate release by, astrocytes and that these astrocyte responses affect the surrounding neurons via neuronal iGluRs (Pasti et al., 1997; Haydon, 2001) . In the present study, the NMDA receptor antagonist MK801 was used to reduce the excitotoxicity of calcium indicator loading of slice preparations, in which the detergent Cremophore was used. We also noted, however, that the washing out of MK801 after loading induced spontaneous, fast, synchronous calcium increases in neurons, in accordance with a previous report that NMDA receptor blockade increases NMDA receptor expression and that the removal of the blocker induces epileptic neuronal activity (Goldin et al., 2001 ); therefore, we were able to use these neuronal calcium increases to investigate the effect of mGluR activation. Consequently, we used calcium imaging of individual pyramidal neurons in slice culture preparations of the neonatal rat hippocampal CA1 region to examine the effect of agents that induce an astrocyte calcium response. Figure 6 shows representative fluorescence images (Fig.  6 A) and time-dependent fluorescence changes in the eight pyramidal neurons marked 1-8 in Figure 6 Ae (Fig. 6 B-D) . Fluorescence images before, and at the peak of, the spontaneous, fast, synchronous calcium increase seen after MK801 washout, derived from imaging data in movie 2 (supplementary data), are shown in Figure 6 , Aa and Ab, respectively. The time-dependent changes in the spontaneous responses before mGluR activation (Fig. 6 B; shown on an expanded scale in Fig. 6C ) also show the synchronous spike-like properties of these calcium increases. Because the spontaneous, fast calcium increase was blocked either by a combination of two iGluR antagonists, 6-cyano-7-nitroquinoxaline-2,3-dione (50 M) and D-(Ϫ)-2-amino-5-phosphonopentanoic acid (50 M), or by the sodium channel blocker tetrodotoxin (1 M) (data not shown), it was probably caused by the synchronous activity of neurons as a result of synaptic transmission. Activation of mGluRs by tACPD significantly affected the calcium response, i.e., the synchronized fast calcium increase was converted to an asynchronous slow calcium oscillation (Fig. 6 B) . Two representative fluorescence images of the calcium oscillation derived from movie 3 (supplementary data) are shown in Figure 6 , Ac and Ad. These results show that tACPD treatment reduced the frequency of the calcium response and made each response independent. Subsequent application of a high concentration of glutamate (1 mM) induced a global calcium increase (Fig. 6 Ae,D), and most of the neurons could be identified. The frequency of the slow calcium increase in the neurons in the slice preparation after tACPD application (1.71 Ϯ 0.11 peaks per minute; n ϭ 8 cells) was similar to that seen in astrocytes cultured in ADM, as described above (2.05 Ϯ 0.14 peaks per minute; n ϭ 228 cells). These results suggest that the intrinsic calcium oscillation in astrocytes influences neuronal activity and supports the idea that the astrocytic calcium response to tACPD results in glutamate release, which induces a calcium response in neighboring neurons via iGluRs, as proposed on the basis of similar experiments using acute slice preparations (Pasti et al., 1997) . Furthermore, the present results show that mGluR activation converts the pattern of neuronal activity and suggest that astrocytes play a dominant role in the neuronal calcium increase after mGluR activation.
Discussion
On the basis of the above findings, we propose the model shown in Figure 7 , in which the astrocytic calcium response is altered by soluble factors, the production of which is affected by the CNS environment, and this change in response then affects the activity of neighboring neurons. The GFs, EGF and bFGF, increase the size of the intracellular calcium store in the astrocyte, which leads to conversion of the neurotransmitter-induced calcium response from transient to oscillatory and promotes proliferation and a hypertrophic morphology, all of which involve the MAPK cascade. The calcium oscillation generated in the astrocyte in response to glutamate leaking from the synaptic cleft during neuronal activity causes repetitive glutamate release, which gives back repetitive excitatory inputs to the neuronal network. In contrast, pro-inflammatory cytokines suppress these changes in the calcium response and morphology by inhibiting the expression of genes downstream of the MAPK cascade. This leads to a reduction in excitatory input from astrocytes to neurons that is influenced by the frequency of glutamate release and contact between the two types of cell.
A broad spectrum of nonexcitable cells show calcium oscillation. The bell-shaped calcium dependency of the IP 3 receptor (Miyakawa et al., 1999) and the dual regulation of regulator of G-protein signaling 4 by calcium and phosphatidylinositol triphosphate (Luo et al., 2001) have been suggested as the possible mechanisms, but no general model explaining all of the phenomena has been presented. Furthermore, there are reports that oscillations in intracellular IP 3 levels are synchronized with calcium oscillations and that spontaneous oscillation of calcium release from the intracellular calcium store is directly stimulated by a low IP 3 concentration (Hajnoczky and Thomas, 1997) . The present results showed that the size of the calcium store, but not mGluR levels, was crucial in generating calcium oscillation in astrocytes. Because the GFs altered the calcium responses to both glutamate and ATP and did not affect mGluR5 expression, this shows that their effect was independent of the type and level of expression of receptors. Furthermore, the calcium response induced by direct activation of IP 3 receptors by thimerosal was also converted from transient to oscillatory by the GFs, suggesting that the GFs affected the properties of the calcium store or some controlling mechanism of calcium dynamics. Measurement of the size of the calcium store using ionomycin showed that enlargement of the calcium store correlated with the generation of the oscillatory calcium response. A similar correlation has been reported in mouse oocytes during maturation (Jones et al., 1995) , suggesting that this is a common mechanism for converting the response pattern under physiological conditions. We assume that GFs increase the size of the calcium store and then increase the duration or total amount of calcium release, which finally affects the local calcium concentration around the IP 3 receptor. Because the IP 3 receptor is regulated by calcium in both a positive and negative manner (Miyakawa et al., 1999) , GFs may affect IP 3 receptor function via the local calcium concentration and produce synchronized calcium release. Another possible explanation for the calcium oscillation is that when GFs increase the size and possibly the distribution of the calcium stores, this may enable the propagation of a calcium wave, which is thought to be one mechanism involved in calcium oscillation (Carafoli, 2002) . If enlargement of the calcium store resulted in a larger region of the astrocyte being involved in the calcium response, it is likely that the local calcium increase propagates as a calcium wave. Some cases of calcium oscillation have been explained as a result of repetitive propagation of calcium waves (Miyazaki et al., 1992; Strahonja-Packard and Sanderson, 1999) , and propagation of the calcium increase was observed during calcium oscillation (see movie 1 in supplementary data). Further analysis of the calcium store in astrocytes, including the calcium concentration in the store in both the resting and stimulated states, the morphology of the endoplasmic reticulum, and the localization of the IP 3 receptor, will provide useful information for examining these two possibilities.
The above-described regulation of calcium oscillation in the astrocyte by GFs and pro-inflammatory cytokines is the first evidence for the dual regulation of calcium dynamics by soluble factors and could be the mechanism by which the astrocyte detects changes in the CNS environment and regulates brain activities, such as the processes of inflammation, regeneration, and memory formation, under various physiological conditions. Because the GFs promoted proliferation and a hypertrophic morphology, in addition to calcium oscillation, an oscillatory calcium response to neurotransmitters could be a property of reactive astrocytes. If this is the case, neurodegeneration during gliosis could be attributed to this calcium oscillation of the astrocyte, which would result in increased glutamate release and cause excitotoxicity. We cannot definitely conclude that the properties of astrocytes cultured in ADM reflect those of reactive astrocytes, however, because the GFs did not cause increased expression of GFAP, which is reported to be increased in reactive astrocytes (Brock and O'Callaghan, 1987) , and it is known that both GFs and pro-inflammatory cytokines are involved in the differentiation of reactive astrocytes (Rostworowski et al., 1997; Iseki et al., 2002) . GFs are produced to some extent in the CNS under normal physiological conditions and act as tropic factors, and their concentrations are altered in response to physical and psychological conditions (Stachowiak et al., 1997; Gomez-Pinilla et al., 1998; Xian and Zhou, 1999) . In contrast, pro-inflammatory cytokine production is suppressed until triggered by events such as brain damage, psychological stress, or aging (Rostworowski et al., 1997; Murray and Lynch, 1998) . On the basis of these two lines of evidence, the percentage of astrocytes showing an oscillatory calcium response is assumed to vary in the normal CNS, mostly depending on the production of GFs, as seen in cells cultured in the presence of 10% FCS. This flexibility in the calcium response could be part of the regulatory mechanism of memory formation, because the astrocytic calcium response to neuronal activity, especially tetanic stimulation, is reported to affect synaptic plasticity (Kang et al., 1998) . This notion is in good agreement with the evidence that synaptic transmission is promoted by GFs (Ishiyama et al., 1991) but reduced by pro-inflammatory cytokines (Murray and Lynch, 1998) . For both sets of factors, the astrocyte would be the main target for regulation of higher brain function. This dual regulation of the MAPK cascade was shown to be crucial in all of the processes described in the present study, and our results are evidence for a novel regulatory mechanism in this cascade, because the presently known negative regulation mechanisms for the MAPK cascade affect signaling between receptors and ERKs, such as MAPK phosphatases (Takaki et al., 2001 ) and sprouty (Hanafusa et al., 2002) .
Most mGluRs have a 10-fold higher affinity than iGluRs for glutamate (Conn and Pin, 1997) , thus allowing a long-lasting calcium response (including calcium oscillation) by the astrocyte to glutamate leaked from the synaptic cleft after massive neuronal activation, e.g., by tetanic stimulation (Porter and McCarthy, 1996) . Furthermore, because neuronal mGluRs are localized in the perisynaptic region (Baude et al., 1993; Lujan et al., 1997) , they are probably activated by the leaked glutamate (Lujan et al., 1997; Mitchell and Silver, 2000) . In the present study on slice cultures, the mGluR agonist tACPD converted the spontaneous, fast, synchronous calcium increase of pyramidal neurons to slow, asynchronous calcium oscillation. Furthermore, the frequency of the calcium oscillation in the neurons in the slice cultures was similar to that of cultured astrocytes, suggesting that the intrinsic calcium oscillation in astrocytes influences neighboring neurons via glutamate release. These results imply that the astrocyte plays a dominant role in neuronal activity after mGluR activation. Further examination of the effects of soluble factors on calcium responses in slice cultures using serum-free medium should reveal how they affect neuronal activity via changes in the astrocyte. Although calcium-dependent glutamate release from astrocytes has been shown in both culture and slice preparation (Bezzi et al., 2001) , it is reported to have both excitatory and inhibitory effects on neuronal activity (Porter and McCarthy, 1996; Araque et al., 1998) , and its real consequence still has to be determined. It is reasonable to assume that the response of neurons to glutamate released by astrocytes is dependent on the subtype of glutamate receptor, which can vary outside synapses, and that the inhibitory effects are caused by inhibitory mGluRs (groups II and III). If this were the case, the physiological role of the calcium response and glutamate release by the astrocyte would vary, depending on the structure and topology of the glutamate release site on the astrocyte and the glutamate-receptive site on the neuron. In conclusion, we propose that the soluble factor-mediated regulation of astrocyte calcium dynamics is a novel mechanism for sensing the state of the CNS environment and responding to it by altering the physiology and pathology of the CNS. Additional studies on this regulatory mechanism should provide significant information on how the brain works.
